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Gene organization and evolutionary history
The  lamins  were  first  characterized  biochemically  as 
prominent 60 to 80 kDa proteins of the nuclear lamina 
and  eventually  identified  as  intermediate  filament  (IF) 
proteins by sequence homology [1-6]. The name inter-
mediate  filament  refers  to  the  average  diameter  of 
assembled  intermediate  fibers  (10  to  12  nm),  which  is 
between that of actin microfilaments (7 to 10 nm) and 
that  of  microtubules  (25  nm)  [7].  The  nuclear  lamins 
repre  sent one (type V) of six subtypes of the IF super-
family,  defined  on  the  basis  of  genomic  structure  and 
nucleotide sequence. Lamins are present only in meta-
zoans and seem to be restricted to the animal kingdom as 
no  obvious  homologs  have  been  identified  in  the  fully 
sequenced  genomes  of  several  lower  eukaryotes, 
including Arabidopsis thaliana, Saccharomyces cerevisiae 
and Schizosaccharomyces pombe.
Nuclear lamins are divided into A and B types on the 
basis of structural and protein features and expression 
patterns.  In  general,  A-type  lamins  resemble  B-type 
lamins  over  the  amino-terminal  head  and  central  rod 
domain,  but  have  an  expanded  carboxy-terminal  tail 
domain that contains a unique 90 amino acid segment 
(Figure  1).  B-type  lamins  are  usually  ubiquitously  ex-
pressed, whereas A-type lamins are expressed in develop-
men  tally  regulated  temporal  patterns.  The  differences 
between A- and B-type lamins in terms of protein struc-
ture, expression, localization patterns and biochem  istry 
have been interpreted to reflect functional diversification.
Relative  to  the  well-conserved  cytoskeletal  proteins 
tubulin and actin, IF proteins and lamins appeared more 
recently in evolutionary time and have undergone large 
divergence in sequence. Current evidence supports the 
hypothesis  that  all  IF  proteins  arose  from  a  common 
lamin-like  progenitor,  because  all  organisms  known  to 
have IF proteins also have lamins, but not all also have 
cytoplasmic IF proteins (the latter would be expected if 
lamins had evolved from a cytoplasmic IF). For example, 
the  Drosophila  genome  encodes  only  two  IF  proteins, 
both of which are nuclear lamins [8], and the cnidarian 
Hydra  vulgaris  genome  encodes  a  single  IF  protein, 
which is also a nuclear lamin [9]. In addition, the expres-
sion patterns of IF proteins indicate that lamins are the 
ancestral founder of the family. Expression of at least one 
lamin in all cell types is essential for viability, in contrast 
to cytoplasmic IFs, which are expressed in a cell-type- 
and  tissue-specific  pattern  [10].  Sequence  comparison 
further supports the notion of lamins as ancestral IFs. A 
lamin-specific  42  amino  acid  segment  is  present  in 
primitive cytoplasmic IF proteins from some invertebrates 
but is absent from cytoplasmic IF proteins from all verte-
brates and most invertebrates [11]. Given that the 42 amino 
acid segment is present in all lamins and some primitive 
cytoskeletal IF proteins, it seems that an ancestral lamin 
gave rise to the primordial cytoplasmic IF proteins, which 
later lost the 42 amino acid signature, probably through an 
exon  deletion  event.  Furthermore,  vertebrate  nuclear 
lamins  are  more  similar  to  invertebrate  cytoplasmic  IF 
proteins  than  they  are  to  vertebrate  cytoplasmic  IF 
proteins, suggesting evolutionary proximity [12].
Summary
The lamins are the major architectural proteins of 
the animal cell nucleus. Lamins line the inside of the 
nuclear membrane, where they provide a platform 
for the binding of proteins and chromatin and confer 
mechanical stability. They have been implicated in 
a wide range of nuclear functions, including higher-
order genome organization, chromatin regulation, 
transcription, DNA replication and DNA repair. The 
lamins are members of the intermediate filament 
(IF) family of proteins, which constitute a major 
component of the cytoskeleton. Lamins are the only 
nuclear IFs and are the ancestral founders of the IF 
protein superfamily. Lamins polymerize into fibers 
forming a complex protein meshwork in vivo and, 
like all IF proteins, have a tripartite structure with two 
globular head and tail domains flanking a central 
α-helical rod domain, which supports the formation 
of higher-order polymers. Mutations in lamins cause a 
large number of diverse human diseases, collectively 
known as the laminopathies, underscoring their 
functional importance.
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© 2011 BioMed Central LtdSeveral lines of evidence support the view that a B-type 
lamin  appeared  before  A-type  lamins.  Almost  all 
invertebrate lamins are B-type lamins, which are more 
similar to vertebrate B-type lamins than A-type lamins. 
Also, some invertebrates contain a single lamin, which is 
always a B-type lamin [9]. The intron-exon structure of 
the lamins supports a model in which a B-type lamin was 
the progenitor [13]. For example, intron positions of the 
human  lamin  B1  gene  (LMNB1)  are  conserved  in  the 
lamin  A/C  (LMNA)  and  lamin  B2  (LMNB2)  genes; 
however, LMNB2 contains an intron between the regions 
encoding coil 1A and coil 1B that is not present in other 
IF  proteins  (including  LMNA),  indicating  that  LMNB2 
and LMNA evolved from an LMNB1-like ancestor [13]. 
Moreover, in organisms with both A- and B-type lamins, 
such  as  mammals,  B-type  lamins  are  constitutively 
expressed in all somatic cells, whereas A-type lamins are 
developmentally  regulated  and  expressed  primarily  in 
differentiated tissues.
A number of structural changes in the lamin sequences 
have occurred during evolution (Figure 2). Accordingly, 
vertebrate  B-type  lamins  can  be  further  classified  into 
three major subtypes: B1, B2 and B3. The B3-type lamins 
are found only in amphibians and fish and are interesting 
because they show the general features of B-type lamins 
but  their  sequence  is  more  similar  to  A-type  lamins 
[14,15].  The  amino  acid  sequence  variation  between 
known B3-type lamins is markedly high, suggesting these 
lamins  represent  an  ancient  vertebrate  lamin.  The 
ancestor  to  all  vertebrate  lamins  acquired  an  acidic 
cluster in the tail domain, which now differentiates them 
from  invertebrate  B-type  lamins  (Figure  2)  [9].  A-type 
lamins have a longer carboxy-terminal tail as a result of a 
unique  90  amino  acid  insertion,  which  probably  arose 
through  an  exon  shuffling  event  [16].  Another  notable 
structural change has occurred in tunicates, where the 
entire immunoglobulin (Ig) domain was deleted from the 
carboxy-terminal tail [17].
Figure 1. Nuclear lamins: domain organization and protein structure. (a) Domain organization of the major lamins in humans. The α-helical 
rod domain comprises four segments, 1A, 1B, 2A, 2B (yellow), which are separated by linker segments, L1, L12 and L2. The tail domain contains a 
nuclear localization signal, an immunoglobulin domain (green), and a conserved CAAX box, which undergoes farnesylation. (b) The structure of a 
portion of the α-helical rod domain corresponding to human lamin A segment 2B (PDB code: 1X8Y) [19]. (c) The structure of the Ig domain from 
human lamin A/C (PDB: 1IFR) [20].
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Page 2 of 14Lamins are alternatively spliced to create multiple iso-
forms.  The  genomes  of  mammals  encode  three  lamin 
genes, LMNA, LMNB1 and LMNB2, which collectively 
express at least seven protein isoforms. LMNA is alter  na-
tively spliced producing at least four isoforms: the two 
major  isoforms  lamin  A  and  C,  and  the  two  minor 
isoforms C2 and AΔ10. Lamin A and C are identical for 
the first 566 amino acids, but lamin C lacks 98 amino 
acids at the carboxyl terminus that are present in pre-
lamin  A  (before  post  translational  processing)  and 
contains  a  unique  six  amino  acid  carboxyl  terminus 
(Figure 1). One major difference between lamins A and C 
is the absence in lamin C of the CAAX box, which is 
modified by farnesylation and has a role in targeting the 
lamins  to  the  inner  nuclear  membrane.  Some  lamin 
isoforms are highly tissue-specific, such as human lamin 
B3, an alternatively spliced isoform of LMNB2, which is 
restricted  to  the  male  germ  line  [18].  Other  lamin 
isoforms,  such  as  lamins  A  and  C,  are  ubiquitously 
expressed  in  virtually  all  differentiated  cells.  The 
Figure 2. Phylogenetic relationships of metazoan lamins. An unrooted phylogenetic tree using an alignment of 31 lamin coding sequences 
[127]. Evolutionary history was inferred using the neighbor-joining method and evolutionary distances were computed using the maximum 
composite likelihood method [128,129]. The tree is drawn to scale with branch lengths proportional to the evolution distances. In general, all 
invertebrate lamins are B-type lamins. The exception is Drosophila LamC, which is considered an A-type lamin [130]. Vertebrate B-type lamins 
subdivide into three separate clades, B1, B2 and B3, the latter being specific to amphibians and fish. A-type lamins evolved from a Lamin B1-like 
ancestor and are unique to vertebrates. Major structural changes of lamins during evolution are indicated: the minus sign indicates a 90 amino acid 
deletion in the conserved Ig domain from tunicates (urochordate subphylum) [9]; the asterisk indicates the addition of 6 to 12 negatively charged 
amino acids within the tail domain of all lamins in the vertebrate lineage [9]; and the plus sign indicates the acquisition of an extra exon (exon 11), 
encoding 90 amino acids, in the tail domain of vertebrate A-type lamins [13].
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Page 3 of 14functional  significance  of  individual  lamin  isoforms  is 
largely unknown. Overall, vertebrates encode more lamin 
genes  and  produce  isoforms  to  a  greater  extent  than 
invertebrates.  Differential  expression  of  different  lamin 
isoforms  creates  functionally  and  structurally  unique 
nuclear  laminas.  Whatever  the  roles  of  each  lamin 
isoform,  it  is  generally  thought  that  increases  in  the 
numbers of lamin isoforms, either by gene duplications 
and/or alternative splicing, may have helped to meet the 
functional  demands  of  increasing  cellular  variety  and 
complexity.
Characteristic structural features
Like  all  IF  proteins,  nuclear  lamins  have  a  tripartite 
structure consisting of a long α-helical domain flanked by 
globular  amino-terminal  (head)  and  carboxy-terminal 
(tail)  domains  (Figure  1).  The  central  α-helical  or  rod 
domain spans approximately half of the lamin molecule 
(about 350 residues) and comprises four α-helical seg-
ments termed 1A, 1B, 2A and 2B. Each α-helical segment 
has  heptad-repeat  periodicity,  characteristic  of  coiled-
coil proteins, and is connected by short intervening sub-
domains denoted L1, L12 and L2. The 2.2 Å structure of 
part of the carboxy-terminal coiled-coil segment 2B from 
human lamin A has been solved (Figure 1b), opening the 
way for more detailed studies on lamin assembly [19]. 
The  amino-terminal  head  domain  of  the  lamins  is 
variable  in  size  but  is  generally  shorter  than  the  same 
domain  found  in  cytoplasmic  IF  proteins  (which  are 
about 40 to 100 residues long). The carboxy-terminal tail 
domain  contains  a  nuclear  localization  signal,  an  Ig 
domain and a CAAX box (Figure 1). The structure of the 
human lamin A/C Ig domain contains a characteristic Ig 
fold  and  forms  a  compact  β  sandwich  comprising  two 
β sheets formed from nine β strands connected by short 
loops [20,21]. The Ig domain is common to many proteins 
and mediates diverse protein-protein and protein-ligand 
interactions, which involve virtually every surface of the 
Ig domain. The Ig domains in lamins are suggested to 
represent a new class on the basis of the connectivity of 
strands  and  the  presence  of  ancillary  β  strands,  which 
may confer unique protein interaction properties [20].
Dimerization, polymerization and higher-order assembly 
of the nuclear lamins
Lamins form extensive higher-order polymers (Figure 3). 
The ultrastructure of the nuclear lamina is best charac-
terized in amphibian oocytes and consists of IF-like lamin 
filaments about 10 nm in diameter arranged in a regular 
woven meshwork pattern [22,23]. This pattern contrasts 
somewhat  with  mammalian  cells,  where  only  irregular 
filamentous meshworks have been observed [24,25].
Lamins  dimerize  using  their  α-helical  rod  domain, 
which  contains  the  characteristic  coiled-coil  heptad 
repeat  pattern.  Coiled-coiled  heptad  repeats  a  and  d 
preferentially contain hydrophobic residues and repeats e 
and g charged residues. Along the axis of the α helix is a 
hydrophobic seam, which acts as a dimerization interface 
between  two  lamin  proteins,  oriented  in  a  parallel, 
unstaggered manner. Each α helix coils around the other, 
resulting in the lamin dimer, the basic building block of 
higher-order lamin assemblies (Figure 3). Electron micro-
scopy  studies  show  that  the  lamin  dimer  forms  a  rod 
about  50  nm  long  flanked  at  one  end  by  two  tightly 
packed  globules,  which  correspond  to  two  globular 
carboxy-terminal tail domains [26]. Interactions between 
A- and B-type lamins are possible. Pre-lamin A, lamin A, 
lamin  B1  and  lamin  C  can  form  homo-  and  hetero-
dimers when ectopically expressed in yeast and in in vitro 
binding  assays  [27,28].  The  precise  abundance  of  each 
species in vivo is not known, but the cellular ratio of the 
lamins is non-stoichiometric [29].
Higher-order polymerization of lamins involves head-
to-tail parallel association between two or more lamin 
dimers, resulting in a lamin polymer (Figure 3). Head-to-
tail association of lamin dimers involves an overlap of the 
highly conserved amino-terminal part of coil 1A and a 
carboxy-terminal part of coil 2B [19]. This head-to-tail 
association  is  unique  to  lamins,  contrasting  with  the 
Figure 3. Schematic model of lamin polymers. Lamin dimers 
form from monomers that associate in a parallel, head-to-head 
manner, forming a coiled coil though the central α-helical domain. 
Lamin polymers then assemble by association of dimers in a polar 
head-to-tail manner through a staggered 2 to 4 nm overlap of the 
highly conserved amino- and carboxy-terminal rod domain ends. 
Protofilaments are finally produced through anti-parallel association 
of two lamin polymers. Between three and four protofilaments 
associate laterally to form an intermediate filament about 10 nm in 
diameter.
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Page 4 of 14overlapping, half-staggered, anti-parallel side-by-side asso-
ciation of dimers observed for cytoplasmic IF proteins. 
The  relatively  short  amino-terminal  head  domain  is 
important for the formation of head-to-tail polymers in 
vitro and for IF formation in vivo [30]. The head domain 
requirement  can  be  traced  to  20  highly  conserved 
residues,  which  include  phosphorylation  sites  for  cell-
cycle  dependent  kinase  2  (CDC2),  which  is  known  to 
have a role in lamin disassembly in mitosis [31].
The  study  of  higher-order  lamin  structures  has  been 
hampered by the difficulty of producing 10-nm filaments 
in vitro. So far, the Caenorhabditis elegans lamin is the 
only  lamin  that  has  been  successfully  assembled  into 
10 nm IF-like filaments in vitro [26,32]. This B-type lamin 
has  a  truncated  carboxy-terminal  tail  domain,  possibly 
explaining  the  different  assembly  properties.  It  is  also 
possible that formation of 10 nm filaments depends on the 
presence of membranes that are absent from the in vitro 
systems. Instead, most lamins form paracrystalline arrays 
in vitro, which display a unique axial repeat pattern [33].
Heterotypic lamin dimers can interact to form mixed 
isoform  polymers  in  vitro  [34].  However,  it  is  unclear 
whether in vivo individual filaments contain both types of 
lamins  within  the  same  filament  or  whether  lamins 
segregate into distinct filaments. Following mitosis, lamin 
A incorporates into the membrane after lamin B, suggest-
ing  that  nuclear  IFs  are  homotypic  [35].  Nevertheless, 
this  does  not  exclude  the  possibility  of  eventual 
reorganization  of  the  nascent  lamina  or  integration  of 
heterotypic interactions, as suggested by high-resolution 
images of a mammalian somatic lamina that demonstrate 
domains  of  segregation  and  domains  of  overlap 
juxtaposed within the same nucleus [24].
Post-translational modifications
Lamins are post-translationally modified in several ways. 
Almost all lamins contain a CAAX box at the carboxyl 
terminus,  which  serves  as  a  substrate  for  post-trans-
lational farnesylation. This is achieved in three successive 
steps  starting  with  the  isoprenylation  of  the  cysteine, 
followed by the proteolytic cleavage of the AAX motif 
and finally the carboxy-methylation of the farnesylated 
cysteine. The hydrophobic farnesyl moiety is thought to 
facilitate  localization  to  and  retention  at  the  nuclear 
envelope. Nevertheless, carboxy-terminal farnesylation is 
not absolutely required for lamina localization because 
lamin C does not contain a CAAX box but does localize 
to the nuclear envelope. Once localized to the nuclear 
envelope, lamin A is processed further by the proteolytic 
removal of the carboxy-terminal 18 amino acids, includ-
ing the farnesyl group, whereas B-type lamins retain the 
farnesyl moiety in their mature form [33].
Lamins  are  phosphorylated  by  multiple  kinases  and 
contain  many  conserved  phosphorylation  sites,  with 
more than 30 known sites in human A-type lamins alone 
[36].  Three  kinases  known  to  modify  and  modulate 
lamins’ activities are CDC2, protein kinase C (PKC) and 
protein  kinase  A  (PKA).  The  mitotic  kinase  CDC2 
induces lamin disassembly by phosphorylating conserved 
residues within the head and coiled-coil 2B domains [31]. 
Phosphorylation  of  Thr19,  Ser22  and  Ser392  causes 
depolymerization  of  lamin  filaments  in  mitosis  and 
meiosis. PKA phosphorylation sites are highly conserved 
and when phosphorylated inhibit lamin polymerization 
[37]. In addition, phosphorylation by PKC is known to 
regulate lamin uptake into the nucleus [38].
Lamin A also has two sumoylation consensus sites, one 
within  the  rod  domain  and  another  within  the  tail 
domain. Substitutions (E203G and E203K) within the rod 
domain disrupt the canonical SUMO E2 site, resulting in 
lower  levels  of  sumoylated  lamin  in  vivo  and  altered 
subnuclear localization [39].
Localization and function
Expression
B-type lamins are constitutively expressed in most cell 
types, whereas A-type lamins are developmentally regu-
lated, being predominantly expressed in most differen-
tiated  cell  types  [40].  However,  certain  cells  of  the 
hemato  poietic system do not express A-type lamins even 
when fully differentiated [41]. In mammalian germ cells 
and pronuclei, expression is limited to the two atypical 
lamin isoforms lamin B3 and C2, respectively, which are 
detected  only  in  germ  cells  but  are  otherwise  not 
expressed  [18,42].  In  fish,  amphibians  and  birds  the 
species-specific lamin B3 (LIII) is expressed in oocytes. 
A-  and  B-type  lamins  are  also  found  in  fertilized 
mammalian eggs until 2 to 4 cleavage divisions, when A-
type  lamins  are  no  longer  detected.  As  embryogenesis 
proceeds, A-type lamins are again detected on day 8 to 9 
in extra-embryonic tissues and on day 12 in the embryo 
itself  [41,43].  Mouse  and  human  embryonic  stem  cells 
express lamins B1 and B2 but not lamins A or C. When 
embryonic stem cells move towards differentiation, lamin 
A/C  is  detected  immediately  before  the  pluripotent 
Oct-3/4  gene  is  downregulated,  and  immediately  after 
stage-specific embryonic antigen-4 (SSEA-4) is activated. 
Interspecies  differences  in  lamin  expression  have  also 
been  noted:  lamin  A  is  highly  expressed  in  circulating 
erythrocytes in Gallus gallus (chicken) but is absent from 
the same cell type in amphibians [44,45]. Because A-type 
lamins  usually  appear  after  cellular  differentiation 
initiates,  it  is  thought  that  A-type  lamins  facilitate 
‘locking-in’ of the differentiated state [41].
Localization
As expected from their incorporation into the lamina, a 
large portion of cellular lamin is found in an insoluble 
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Page 5 of 14pool at the nuclear rim (Figure 4). There is also a pool of 
A-type lamins within the nucleoplasm, which is distinct 
from  peripheral  lamin  A,  in  that  it  is  probably  not 
polymerized and is more soluble [46]. The assembly state, 
fraction,  purpose  and  function  of  the  nucleoplasmic 
lamin A are still unknown [47,48]. Similarly, B-type lamins 
are also present in the nucleoplasm. In vivo dynamics of 
lamins in interphase nuclei have been studied by various 
techniques, including fluorescence recovery after photo-
bleaching  and  fluorescence  correlation  spectroscopy 
[24,35,49-51].  In  contrast  to  cytoplasmic  IF  proteins, 
which  seem  very  dynamic,  nuclear  lamins  are  relatively 
stable once integrated into the nuclear lamina [49]. Where  as 
nucleoplasmic lamin A/C is highly mobile, nucleoplasmic 
lamins B1 and B2 are relatively immobile, indicating that 
A- and B-type lamins have separate organi  zational states 
[24].  Cell-cycle-related  changes  to  lamin  protein 
dynamics have also been reported. For instance, lamina-
associated  lamin  B1  associates  with  the  lamina  with  a 
half-life of about 10 minutes during the initial stages of 
G1, which increases to about 2 hours in a later part of G1 
[35].
Lamins have pivotal roles in nuclear reassembly after 
cell division. During mitosis, when the nuclear envelope 
breaks down and the lamina disassembles, A-type lamins 
are solubilized and distributed throughout the cytoplasm, 
whereas B-type lamins maintain close associations with 
the  nuclear  membrane.  The  differences  in  membrane 
attachment during mitosis are attributed to whether the 
lamin protein is farnesylated. Mature lamin B retains its 
farnesylation moiety, which anchors B-type lamins to the 
membrane  during  mitosis,  whereas  the  farnesylation 
moiety  is  removed  from  lamin  A,  rendering  it  more 
soluble [52]. To facilitate disassembly of the lamina, lamins 
are phosphorylated by PKC and are dephosphorylated by 
type 1 protein phosphatase during reassembly [53]. When 
a  nascent  nuclear  envelope  forms  around  condensed 
chromosomes,  A-type  lamins  are  imported  into  the 
nucleus along with additional B-type lamins [35,54].
Lamins are early targets for caspase degradation in cells 
undergoing apoptosis [55,56]. Caspase-6 and caspase-3 
are  the  major  proteases  responsible  for  A-  and  B-type 
lamin degradation [57]. At the onset of apoptosis, before 
detectable  DNA  cleavage  or  chromatin  condensation 
occurs,  lamins  are  cleaved  at  caspase  recognition  sites 
located within the L12 linker region and expression of 
uncleavable  mutant  lamin  protein  delays  the  onset  of 
apoptosis  [58].  Time-lapse  experiments  of  green-
fluorescent-protein-tagged lamins suggest that A- and B-
type lamins have different dynamics following their initial 
cleavage  [59].  A-type  lamins  are  thought  to  rapidly 
translocate to the nucleoplasm and cytoplasm, whereas 
B-type lamins remain at the nuclear periphery.
Mechanisms
Mechanical properties of the nucleus
From their primary sequence and their grouping within 
the IF superfamily, the lamins were originally hypothesized 
Figure 4. Nuclear lamins: localization at the nuclear periphery and within the nucleoplasm. Immunofluorescence staining of lamin A/C (red) 
and lamin B1 (green) in U2OS human osteosarcoma cell and MEF cell nuclei, respectively.
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conceivably as tensegrity elements that specify nuclear 
morphology  and  resistance  to  deformation  [22].  In 
support of this, studies using Xenopus nuclear assembly 
systems show that cell-free extracts depleted of lamins 
assemble  small  and  fragile  nuclei  [60].  Conversely, 
ectopic  expression  of  the  germ-cell-specific  lamin  B3 
isoform, which lacks the amino terminus and part of the 
α-helical domain, in somatic cells induces a hook-shaped 
nuclear morphology reminiscent of spermatocytes [61]. 
Additional studies have demonstrated that human cells 
expressing  a  variety  of  lamin  mutations  often  show  a 
range of nuclear morphological phenotypes [62]. Fibro-
blast nuclei from Lmna-/- mice are deformed more easily 
and to a greater extent than those from Lmna+/+ litter-
mates [63]. These nuclei are also more fragile, less resis-
tant to physical compression, and deform in an isotropic 
manner,  in  contrast  to  the  anisotropic  deformation 
observed  in  Lmna+/+  nuclei  [64].  Furthermore,  the 
absence  of  lamin  A/C  from  embryonic  stem  cells  has 
been suggested as an explanation for the more malleable 
and deformable nuclei of this cell type [65]. The extent of 
B-type lamin involvement in nuclear mechanics is not as 
well understood because loss of lamin B1 from murine 
embryonic  fibroblasts  (MEFs)  causes  nuclear  blebbing, 
but does not seem to affect mechanical properties [66].
Protein interactions
In addition to A- and B-type lamin interactions, numerous 
functionally diverse proteins are known to interact with 
the  nuclear  lamins,  including  retinoblastoma  1,  c-Fos, 
thymopoietin (LAP2) and emerin (Figure 5). Lamins are 
part  of  a  nuclear  framework  supporting  multi-protein 
complexes  involved  in  several  nuclear  functions.  The 
majority  of  lamin-interacting  proteins  identified  so  far 
come from studies focused on A-type lamins. More than 
30 direct and more than 100 indirect interactions have 
been  identified  using  various  proteomics-based  studies 
[67,68]. The extensive list of interaction partners further 
supports  the  notion  of  the  lamina  functioning  as  an 
intranuclear platform. The nature and function of each 
interaction probably varies, possibly in a tissue-specific 
manner. Analyses of the nuclear envelope from multiple 
tissues show the protein complement is highly variable 
between  tissues,  supporting  a  model  of  tissue-specific 
lamin A/C roles [69].
Cytoskeletal connections
Nuclei  are  mechanically  linked  to  the  cytoskeleton 
through lamin-interacting proteins that span the nuclear 
envelope  (Figure  5).  This  linker  of  nucleoskeleton  and 
cytoskeleton  (LINC)  complex  consists  of  lamin-inter-
acting  proteins  SUN1  or  SUN2,  which  span  the  inner 
nuclear membrane where they, in turn, interact with a 
member of the nesprin family of proteins in the luminal 
space [70]. Nesprins span the outer nuclear membrane, 
where they associate in the cytoplasm with various cyto-
skeletal elements. The LINC complex has been implicated 
in  serving  functions  important  for  nuclear  migration, 
positioning, morphology and mechanics [71,72].
Lamins and chromatin
Lamins  are  global  regulators  of  chromatin  (Figure  5). 
Transcriptionally silent regions of the genome, such as 
centromeres, telomeres and the inactive X chromosome, 
are  preferentially  positioned  at  the  nuclear  lamina 
[73,74].  A  direct  role  for  lamins  in  the  regulation  of 
chromatin  was  demonstrated  in  studies  of  cardio  myo-
cytes and MEFs derived from Lmna-/- mice, which show a 
partial loss of peripheral heterochromatin, ectopic chromo-
some condensation and mis-positioning of centro  meric 
heterochromatin [75-77]. Disengagement and/or loss of 
heterochromatin are also observed in cells expressing a 
variety  of  mutant  lamin  A  proteins  [78-80].  Global 
hetero  chromatic changes induced by lamin perturbation 
are often mirrored by altered levels of chromatin-asso-
ciated epigenetic histone marks; for example, decreased 
levels of the heterochromatin markers histone H3 lysine 
9  trimethylation  (H3K9me3)  and  H3K27me3  and 
increased levels of H4K20me3. Ectopic lamin expression 
also  influences  chromatin  organization  and  associated 
histone  marks;  for  example,  hypermethylated  H3K4,  a 
mark of active genes, decreases following overexpression 
of wild-type lamin A in C2C12 myoblasts [81].
Lamins have at least two chromatin-binding regions. 
One chromatin interaction domain is located in the tail 
region between the end of the rod domain and the Ig 
domain, and the other is within the rod domain [82,83]. 
Chromatin interactions are probably mediated through 
histones  and/or  chromatin-associated  proteins,  but 
lamins  bind  nonspecifically  to  DNA  in  vitro  through 
contacts in the minor groove of the double helix [82,84]; 
however,  lamins  associate  with  sequences  known  as 
scaffold/matrix attachment regions, which are involved 
in transcriptional regulation, DNA replication, chromo-
some  condensation  and  chromatin  organization  [85]. 
Genome-wide  mapping  techniques  have  identified 
genome regions that preferentially associate with lamins, 
known  as  lamin-A-associated  domains  (LADs)  [86]. 
These domains are generally gene-poor and are proposed 
to represent a repressive chromatin environment.
DNA damage and repair
Recent studies have hinted at a role for lamins in DNA 
repair. Most of these studies have focused on the effects 
of  expressing  an  unprocessed  lamin  A  protein,  which 
causes the premature aging disorder Hutchinson Gilford 
Progeria Syndrome (HGPS). The mutant lamin A protein, 
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deletion  in  the  tail  domain  and  consequently  remains 
permanently farnesylated. Cells expressing progerin have 
a delayed recruitment of the repair factor p53-binding 
protein (53BP1) to sites of DNA damage, show increased 
levels of the double-stranded break marker γ-H2AX, and 
are  more  sensitive  to  DNA  damaging  agents  [87]. 
Progerin  expression  also  affects  the  localization  and 
expression of the key DNA damage regulators ATR and 
ATM and the double-stranded break repair factors Rad50 
and Rad51 [88]. Taken together, these studies suggest the 
necessity of normal lamin A function in repair of DNA 
damage. However, the mechanistic details linking lamins 
and DNA damage have yet to be fully elucidated.
Cellular signaling
Many  studies  have  documented  a  link  between  lamins 
and signal transduction pathways important for cellular 
differentiation and homeostasis (Figure 5) [89]. Through 
protein-protein interactions, lamins are thought to regu-
late the activity and availability of proteins within signal-
ing  cascades,  including  the  retinoblastoma  (Rb)/E2F, 
Wnt/β-catenin,  transforming  growth  factor  (TGF)β/
Mothers against Decapentaplegic (SMAD) and mitogen 
activating protein (MAP) kinase pathways. A well charac-
terized  example  is  AP1  (Jun/Fos)  regulation  through 
extracellular signal-regulated kinase (ERK)/MAP kinase 
signaling. In this case, mitogen stimulation leads to the 
phosphorylation of ERK1/2, causing it to translocate into 
the nucleus. Once there, phosphorylated ERK1/2 binds 
to lamin A and phosphorylates c-Fos, which is normally 
sequestered at the nuclear envelope through interaction 
with lamin A. The phosphorylation of c-Fos causes its 
release from the nuclear envelope, allowing dimerization 
with c-Jun and activation of AP1 immediate-early genes 
[90].  Another  example  is  the  regulation  of  SMAD 
Figure 5. Functions of the nuclear lamina. A cartoon representation of the nuclear lamina, highlighting four key functions. (a) The lamina 
regulates genome organization and chromatin structure by direct interactions with chromatin and indirectly through association with chromatin-
modifying and regulatory proteins. (b) The lamina regulates gene expression by sequestering transcription factors at the nuclear envelope, which 
limits their availability in the nucleoplasm. (c) It also mediates structural linkages between the nucleus and cytoskeleton, through the LINC complex 
consisting of lamins, an inner nuclear membrane protein, and an interacting outer nuclear membrane protein, which in turn binds cytoskeletal 
elements. (d) The lamina also provides a platform for assembly of protein complexes involved in signal transduction pathways. P, phosphate.
Cytoplasm
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     interactions
(b) Sequestration of 
  transcription factors
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[91]. Following induction, SMADs are phosphorylated by 
TGFβ-receptor  kinases,  which  stimulate  their  binding 
with  co-SMADs,  accumulation  in  the  nucleus,  and 
assembly with gene-specific transcription factors. A-type 
lamins modulate SMAD activity by binding to SMADs 
and promoting inactivation through their sequestration 
at the nuclear envelope. A-type lamins can also bind the 
SMAD  antagonists  MAN1  and  PP2A,  which  dampen 
SMAD activity through sequestration and dephosphory-
lation [92].
Transcription
Several lines of evidence support the view that lamins 
mediate transcriptional regulation. Developmentally asso-
ciated changes in lamin expression often coincide with 
increased RNA polymerase II activity and accumulation 
of cell-type-specific transcripts [93]. Disruption of lamin 
organization,  by  expressing  dominant-negative  A-type 
lamins,  inhibits  RNA  polymerase  II  transcription  and 
perturbs the localization of the initiation factor TATA-
binding  protein  [94,95].  Lamin  A/C  associates  with 
numerous  transcriptional  regulators,  either  directly  or 
indirectly, including Rb, Gcl, Mok2, cFos and Srebp1 [96]. 
The  transcription  factor  Oct-1  is  sequestered  at  the 
nuclear  envelope  through  associations  with  lamin  B1, 
which is important for its regulation of oxidative stress 
gene  expression  [97].  Thus,  lamins  bind  many  trans-
criptional regulators and can affect gene expression by 
sequestration  of  these  factors  or  by  influencing  the 
assembly of core transcriptional complexes [90,97].
DNA replication
Lamins  have  also  been  implicated  in  replication.  In 
assembly  systems,  lamin-depleted  Xenopus  nuclear 
extracts produce nuclei that are no longer competent to 
replicate their DNA [60,98]. Additional support comes 
from an observed colocalization of lamins with sites of 
bromodeoxyuridine incorporation and at replication foci 
with proliferating cell nuclear antigen (PCNA) [99-101]. 
Expression  of  dominant-negative  lamin  B  mutants, 
lacking  the  central  rod  domain,  has  been  reported  to 
inhibit DNA replication [102-104].
Human diseases: the laminopathies
Lamins have more recently garnered a surge of interest 
because of discoveries that lamin mutations, primarily in 
LMNA, are associated with numerous heritable human 
diseases [105-108]. These ‘laminopathies’ currently com-
prise 17 distinct diseases and include forms of cardio-
myo  pathy, muscular dystrophy, lipodystrophy and aging-
related  progeria  (Figure  6).  Laminopathies  manifest 
predominantly in mesenchymal tissues, such as skeletal 
muscle, heart, adipose tissue, connective tissue and bone, 
and fall into two general groups: those that affect specific 
tissues  in  an  isolated  manner  and  those  involving 
multiple tissue systems. There is significant phenotypic 
overlap in laminopathies, leading to the suggestion that 
laminopathies  are  a  ‘functional  continuum’  of  related 
diseases rather than separable disorders [109].
About  90%  of  known  disease-associated  polymor-
phisms  are  missense  mutations,  which  are  distributed 
throughout the lamin A/C protein [110]. A clear genotype-
phenotype  relationship  has  not  emerged  despite  the 
description of over 1,000 sequence polymorphisms and 
about 350 disease-associated mutations (Figure 6). The 
creation of mouse models based on laminopathy muta-
tions has provided some clues [111]. Efforts to unravel 
and  explain  the  pathophysiological  mechanisms  are 
possibly  confounded  by  largely  unexplored  genetic 
modifiers [112-114].
In contrast to numerous LMNA-related diseases, only 
two diseases are reported to be associated with mutations 
in  the  LMNB1  and  LMNB2  genes.  A  duplication  of 
LMNB1 resulting in higher LMNB1 dosage/expression in 
brain tissues is associated with the neurological condition 
autosomal-dominant leukodystrophy [107]. Several rare 
LMNB2 missense mutations are purportedly associated 
with  acquired  partial  lipodystrophy  [106].  The  finding 
that  expression  of  at  least  one  B-type  lamin  in  mam-
malian cells is essential for viability, and their ubiquitous 
expression, might explain the relative paucity of LMNB-
associated  diseases  [10].  This  seems  to  be  the  case 
because homozygous mice carrying insertional mutations 
in LMNB1 die at birth with lung and bone defects. Mice 
deficient for lamin B2 also die postnatally and display a 
lissencephaly phenotype, due in part to disrupted nuclear 
movement that is linked to defective neuronal migration 
[115].
The pathological mechanisms of these diseases remain 
obscure, although several models have been proposed. In 
a  structural  model,  expression  of  lamin  A/C  variants 
causes  nuclear  fragility  and  increased  sensitivity  to 
physical stressors [116]. Other models have focused on 
the cellular roles of lamins, suggesting that LMNA muta-
tions alter normal gene expression profiles, either directly 
through chromatin interactions or indirectly by disrupt-
ing protein-protein interactions [116]. One challenge has 
been to adequately explain how ubiquitously expressed 
proteins give rise to tissue-restricted diseases. The tissue-
specific lamin A/C model predicts the existence of tissue-
specific  lamin  A/C  partners  whose  interaction  is 
disrupted by particular lamin A protein variants.
Lamins  are  misregulated  in  some  cancers,  possibly 
making them useful as biomarkers. A-type lamin expres-
sion is decreased by about 80% in small-cell lung cancer 
lines but is high and unchanged in non-small-cell lung 
cancer lines [117]. Similarly, in primary lung carcinomas, 
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Page 9 of 14Figure 6. Summary of disease-associated LMNA mutations mapped onto the human lamin A protein [110]. Colors indicate the class of 
disease. Red, laminopathies with preferential involvement of skeletal and cardiac muscle, which range from muscle-wasting muscular dystrophies 
to cardiac conduction defects; blue, lipodystrophies, which specifically affect adipose tissues; brown, neuropathy disorders, which affect the motor 
and sensory neurons of the peripheral nervous system; green, ‘systemic’ laminopathies, which are heterogeneous disorders involving multiple 
tissue systems; purple, mutations associated with premature aging disorders. Mutations affecting amino acids 1 to 566 affect both lamin A and C 
isoforms, whereas mutations found in the carboxy-terminal 566 to 664 amino acids are specific to the lamin A isoform. fs, frameshift; del, deletion; 
ins, insertion; c, coding.
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Page 10 of 14primarily A-type but also to some extent B-type lamins 
show reduced expression [118], and both A- and B-type 
lamins  are  undetectable  or  reduced  in  most  primary 
colon carcinomas, adenomas and primary gastric cancers 
[119].  However,  reduced  lamin  expression  does  not 
always correlate with cancer tissues. Lamin A/C showed 
higher  expression  in  cutaneous  squamous  cell  carci-
nomas than in normal skin [120,121]. Paradoxically, the 
absence of lamin A in basal cell carcinomas is correlated 
with rapid tumor proliferation rates, whereas the absence 
of lamin C is correlated with a slower proliferation rate. 
Lamin  A  is  reported  to  be  a  promising  biomarker  for 
grading prostate cancers and may aid in prognosis [122]. 
In  addition,  increased  levels  of  A-type  lamins  in  colo-
rectal cancer tissues correlates with a twofold increase in 
cancer-related mortality [123]. Lamin B1 is upregulated 
in hepatocellular carcinoma tumors and correlates with 
tumor size, stage and nodule number [124]. Furthermore, 
elevated levels of plasma lamin B1 can predict early stage 
hepatocellular carcinoma and might also prove to be a 
useful clinical biomarker for colorectal cancers [124,125].
Frontiers
As architectural proteins of the nucleus, the lamins are 
positioned  at  the  intersection  of  numerous  diverse 
nuclear  processes.  Lamins  are  among  the  most 
prominent and best studied proteins in animals, yet many 
of their properties remain unknown. The lamin protein 
family is especially intriguing in light of its association 
with a large number of human diseases. Unraveling the 
basic functions of lamins will be essential to shed light on 
the molecular mechanisms of these diseases.
The  meshwork  of  10  nm  filaments  is  the  functional 
entity  of  lamins  that  must  be  understood  if  we  are  to 
understand  different  lamin  properties  and  the  conse-
quences  of  lamin  mutations.  Already,  some  disease-
associated lamin mutations are known to affect lamina 
formation  [126].  Defective  lamin  assemblies  may 
ultimately have an impact on the mechanical properties 
of the nucleus and/or interfere with nuclear processes, 
including signaling, nuclear import, transcription, DNA 
replication and DNA repair. A better understanding of 
the  composition  of  the  lamina  and  the  influence  of 
different lamin isoforms on its formation and function 
will provide additional important clues. Perhaps the most 
important goal will be to understand the tissue-specificity 
of  lamins.  Why  do  some  LMNA  mutations  affect  a 
particular  tissue  or  subset  of  tissues  despite  near-
ubiquitous expression of lamin A in all tissues? And why 
do different LMNA mutations manifest as dramatically 
different diseases?
Published: 31 May 2011
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